InnovAge Holding Corp.
INNVNASDAQHealthcare● Active
$7.39
+$0.09(+1.23%)
Market Cap$1.0B
P/E Ratio—
52W High$10.69
52W Low$3.13
InnovAge Holding Corp. (INNV) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
INNV · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
-$0.22
Est. $0.06 · -466.7%
Revenue
$0.25B
Est. $0.23B · +7.5%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
INNV reports quarterly as a NASDAQ-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 15, 2026 | $0.07 | — | — | — | $0.24B | — |
| ◌ Q3 FY2026 | Sep 8, 2026 | $0.07 | — | — | — | $0.25B | — |
| ▼ Q2 FY2026 | May 5, 2026 | $0.06 | -$0.22 | -466.7% | $0.25B | $0.23B | +7.5% |
| ▲ Q1 FY2026 | Feb 3, 2026 | $0.04 | $0.08 | +100.0% | $0.24B | $0.23B | +5.0% |
| ▲ Q4 FY2025 | Nov 4, 2025 | $0.01 | $0.06 | +500.0% | $0.22B | $0.23B | -3.8% |
| ▲ Q3 FY2025 | Sep 9, 2025 | -$0.02 | -$0.01 | +50.0% | $0.22B | $0.22B | -0.8% |
| ▼ Q2 FY2025 | May 6, 2025 | -$0.02 | -$0.08 | -300.0% | $0.22B | $0.22B | -0.8% |
| ▼ Q1 FY2025 | Feb 4, 2025 | -$0.01 | -$0.10 | -900.0% | $0.21B | $0.21B | -2.4% |
Q3 FY2026
Sep 15, 2026
EPS Actual
—
EPS Est.
$0.07
EPS Surpr.
—
Revenue
—
Q3 FY2026
Sep 8, 2026
EPS Actual
—
EPS Est.
$0.07
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 5, 2026Miss
EPS Actual
-$0.22
EPS Est.
$0.06
EPS Surpr.
-466.7%
Revenue
$0.25B
Q1 FY2026
Feb 3, 2026Beat
EPS Actual
$0.08
EPS Est.
$0.04
EPS Surpr.
+100.0%
Revenue
$0.24B
Q4 FY2025
Nov 4, 2025Beat
EPS Actual
$0.06
EPS Est.
$0.01
EPS Surpr.
+500.0%
Revenue
$0.22B
Q3 FY2025
Sep 9, 2025Beat
EPS Actual
-$0.01
EPS Est.
-$0.02
EPS Surpr.
+50.0%
Revenue
$0.22B
Q2 FY2025
May 6, 2025Miss
EPS Actual
-$0.08
EPS Est.
-$0.02
EPS Surpr.
-300.0%
Revenue
$0.22B
Q1 FY2025
Feb 4, 2025Miss
EPS Actual
-$0.10
EPS Est.
-$0.01
EPS Surpr.
-900.0%
Revenue
$0.21B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2028 | $0.07 | $0.07 | $0.08 | 1 |
| Q1 FY2028 | $0.12 | $0.12 | $0.12 | 1 |
| Q4 FY2027 | $0.11 | $0.11 | $0.11 | 1 |
| Q3 FY2027 | $0.07 | $0.08 | $0.08 | 1 |
| Q2 FY2027 | $0.06 | $0.06 | $0.07 | 1 |
| Q1 FY2027 | $0.12 | $0.12 | $0.12 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2028 | $0.3B | $0.3B | $0.3B | 1 |
| Q1 FY2028 | $0.3B | $0.3B | $0.3B | 1 |
| Q4 FY2027 | $0.3B | $0.3B | $0.3B | 1 |
| Q3 FY2027 | $0.3B | $0.3B | $0.3B | 1 |
| Q2 FY2027 | $0.3B | $0.3B | $0.3B | 1 |
| Q1 FY2027 | $0.3B | $0.3B | $0.3B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 5, 2026 | -466.7% | $8.17 | $7.96 | -2.57% |
| ▲ Q1 FY2026 | Feb 3, 2026 | +100.0% | $5.70 | $5.66 | -0.70% |
| ▲ Q4 FY2025 | Nov 4, 2025 | +500.0% | $4.74 | $4.84 | +2.11% |
| ▲ Q3 FY2025 | Sep 9, 2025 | +50.0% | $4.03 | $4.27 | +5.96% |
| ▼ Q2 FY2025 | May 6, 2025 | -300.0% | $2.89 | $2.85 | -1.38% |
| ▼ Q1 FY2025 | Feb 4, 2025 | -900.0% | $3.53 | $3.69 | +4.53% |
| ▼ Q4 FY2024 | Nov 5, 2024 | -5.3% | $5.90 | $6.07 | +2.88% |
| ▼ Q3 FY2024 | Sep 10, 2024 | -62.1% | $6.28 | $6.18 | -1.59% |
Q2 FY2026-2.57%
Report Date
May 5, 2026
EPS Beat/Miss
-466.7%
Price Before
$8.17
Price After
$7.96
Q1 FY2026-0.70%
Report Date
Feb 3, 2026
EPS Beat/Miss
+100.0%
Price Before
$5.70
Price After
$5.66
Q4 FY2025+2.11%
Report Date
Nov 4, 2025
EPS Beat/Miss
+500.0%
Price Before
$4.74
Price After
$4.84
Q3 FY2025+5.96%
Report Date
Sep 9, 2025
EPS Beat/Miss
+50.0%
Price Before
$4.03
Price After
$4.27
Q2 FY2025-1.38%
Report Date
May 6, 2025
EPS Beat/Miss
-300.0%
Price Before
$2.89
Price After
$2.85
Q1 FY2025+4.53%
Report Date
Feb 4, 2025
EPS Beat/Miss
-900.0%
Price Before
$3.53
Price After
$3.69
Q4 FY2024+2.88%
Report Date
Nov 5, 2024
EPS Beat/Miss
-5.3%
Price Before
$5.90
Price After
$6.07
Q3 FY2024-1.59%
Report Date
Sep 10, 2024
EPS Beat/Miss
-62.1%
Price Before
$6.28
Price After
$6.18
Avg Beat Reaction+2.46%
Avg Miss Reaction+0.37%
Beat Rate3 / 8 quarters
Largest Move+5.96% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: INNV ends December
InnovAge Holding Corp. (INNV) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $-0.22 — missing the analyst consensus of $0.06 by -466.7%. The next INNV earnings date is expected around September 1, 2026.
Each quarter, investors track INNV earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. INNV revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
INNV's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
INNV earnings · 5 questionsInnovAge Holding Corp.'s next earnings report is expected around September 1, 2026. INNV typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; INNV historically reports after market close (AMC).
INNV earnings datewhen is INNV earningsINNV next earnings datewhen does INNV report earningsINNV earnings calendar
▸ Source: FMP · InnovAge Holding Corp. SEC filings · US GAAP · InnovAge Holding Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026